RAMM Pharma Corp. (CSE:RAMM)

RAMM Pharma Statistics

Total Valuation

RAMM Pharma has a market cap or net worth of CAD 2.39 million. The enterprise value is 1.46 million.

Market Cap	2.39M
Enterprise Value	1.46M

Important Dates

The next estimated earnings date is Friday, June 26, 2026.

Earnings Date	Jun 26, 2026
Ex-Dividend Date	n/a

Share Statistics

RAMM Pharma has 119.39 million shares outstanding.

Current Share Class	119.39M
Shares Outstanding	119.39M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	31.43%
Owned by Institutions (%)	0.01%
Float	81.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.93
PB Ratio	0.49
P/TBV Ratio	0.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.17
EV / Sales	0.57
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.32

Financial Position

The company has a current ratio of 0.66, with a Debt / Equity ratio of 0.01.

Current Ratio	0.66
Quick Ratio	0.40
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.06
Interest Coverage	-17.70

Financial Efficiency

Return on equity (ROE) is -99.83% and return on invested capital (ROIC) is -30.19%.

Return on Equity (ROE)	-99.83%
Return on Assets (ROA)	-22.12%
Return on Invested Capital (ROIC)	-30.19%
Return on Capital Employed (ROCE)	-86.81%
Weighted Average Cost of Capital (WACC)	15.24%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.21
Inventory Turnover	1.25

Taxes

In the past 12 months, RAMM Pharma has paid 104,533 in taxes.

Income Tax	104,533
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +33.33% in the last 52 weeks. The beta is 0.63, so RAMM Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	+33.33%
50-Day Moving Average	0.04
200-Day Moving Average	0.04
Relative Strength Index (RSI)	42.59
Average Volume (20 Days)	69,557

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RAMM Pharma had revenue of CAD 2.56 million and -8.65 million in losses. Loss per share was -0.07.

Revenue	2.56M
Gross Profit	761,566
Operating Income	-4.25M
Pretax Income	-8.54M
Net Income	-8.65M
EBITDA	-3.78M
EBIT	-4.25M
Loss Per Share	-0.07

Balance Sheet

The company has 985,374 in cash and 61,301 in debt, with a net cash position of 924,073 or 0.01 per share.

Cash & Cash Equivalents	985,374
Total Debt	61,301
Net Cash	924,073
Net Cash Per Share	0.01
Equity (Book Value)	4.89M
Book Value Per Share	0.04
Working Capital	-1.22M

Cash Flow

In the last 12 months, operating cash flow was -1.14 million and capital expenditures 25,000, giving a free cash flow of -1.11 million.

Operating Cash Flow	-1.14M
Capital Expenditures	25,000
Depreciation & Amortization	482,525
Net Borrowing	-101,255
Free Cash Flow	-1.11M
FCF Per Share	-0.01

Margins

Gross Margin	29.71%
Operating Margin	-165.68%
Pretax Margin	-333.24%
Profit Margin	n/a
EBITDA Margin	-147.53%
EBIT Margin	-165.68%
FCF Margin	n/a

Dividends & Yields

RAMM Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-362.10%
FCF Yield	-46.50%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RAMM Pharma has an Altman Z-Score of -13.42 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-13.42
Piotroski F-Score	2